(Total Views: 541)
Posted On: 10/01/2020 6:51:18 PM
Post# of 145248
Thanks for the quick math. Hopefully they have a plan to speed the enrollment up here in the U.S. I figure enrollment is slow as COVID cases have decreased while competitor trials have increased. I don’t doubt it’s hard for a small biotech to compete with the BP’s with deep pockets. The U.K. sites need to start enrolling as well but I know their cases are far fewer than the U.S.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)